c-IAP1 is Overexpressed in HL-60 Cells Selected for Doxorubicin Resistance: Effects on Etoposide-induced Apoptosis

Anticancer Research

Volumn 23, Issue 5 A, 2003, Pages 3657-3661

  Vaziri, Susan A J ^a   Grabowski, Dale R ^a   Tabata, Masahiro ^a   Holmes, Katherine A ^a   Sterk, Joseph ^a   Takigawa, Nagio ^a   Bukowski, Ronald M ^a   Ganapathi, Mahrukh K ^a   Ganapathi, Ram ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; c IAP1; Etoposide; Inhibitor of calcium calmodulin dependent enzymes; KN 62; Topoisomerase II targeting drug resistance

Indexed keywords

1 [N,O BIS(5 ISOQUINOLINESULFONYL) N METHYLTYROSYL] 4 PHENYLPIPERAZINE; CYTOCHROME C; DOXORUBICIN; ETOPOSIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR;

APOPTOSIS; ARTICLE; CELL ASSAY; DNA DAMAGE; DOWNSTREAM PROCESSING; DRUG RESISTANCE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME RELEASE; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MITOCHONDRION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; WESTERN BLOTTING;

1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CASPASES; DNA DAMAGE; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; ETOPOSIDE; GENE EXPRESSION REGULATION, LEUKEMIC; HL-60 CELLS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; PROTEIN BIOSYNTHESIS; PROTEINS; UP-REGULATION;

EID: 0344442296     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Chen AY and Liu LF: DNA topoisomerases: essential enzymes and lethal targets. Annu Rev Pharmacol Toxicol 34: 191-218, 1994.
2. Chin KV, Pastan I and Gottesman MM: Function and regulation of the human multidrug resistance gene. Adv Cancer Res 60: 157-180, 1993.
3. Ganapathi R, Constantinou A, Kamath N, Dubyak G, Grabowski D and Krivacic K: Resistance to etoposide in human leukemia HL-60 cells: reduction in drug-induced DNA cleavage associated with hypophosphorylation of topoisomerase II phosphopeptides. Mol Pharmacol 50: 243-248, 1996.
4. Ganapathi R, Hoeltge G, Casey G, Grabowski D, Neelon R and Ford J: Acquisition of doxorubicin resistance in human leukemia HL-60 cells is reproducibly associated with 7q21 chromosomal anomalies. Cancer Genet Cytogenet 86: 116-119, 1996.
5. Aoyama M, Grabowski DR, Dubyak GR, Constantinou AI, Rybicki LA, Bukowski RM, Ganapathi MK, Hickson ID and Ganapathi R: Attenuation of drug-stimulated topoisomerase II-DNA cleavable complex formation in wild-type HL-60 cells treated with an intracellular calcium buffer is correlated with decreased cytotoxicity and site-specific hypophosphorylation of topoisomerase IIalpha. Biochem J 336: 727-733, 1998.
6. Aoyama M, Grabowski DR, Holmes KA, Rybicki LA, Bukowski RM, Ganapathi MK and Ganapathi R: Cell cycle phase specificity in the potentiation of etoposide-induced DNA damage and apoptosis by KN-62, an inhibitor of calcium-calmodulin-dependent enzymes. Biochem Pharmacol 61: 49-54, 2001.
7. Kawamura K, Grabowski D, Krivacic K, Hidaka H and Ganapathi R: Cellular events involved in the sensitization of etoposide-resistant cells by inhibitors of calcium-calmodulin-dependent processes. Role for effects on apoptosis, DNA cleavable complex, and phosphorylation. Biochem Pharmacol 52: 1903-1909, 1996.
8. Yen A, Reece SL and Albright KL: Dependence of HL-60 myeloid cell differentiation on continuous and split retinoic acid exposures: precommitment memory associated with altered nuclear structure. J Cell Physiol 118: 277-286, 1984.
9. Tabata M, Tabata R, Grabowski DR, Bukowski RM, Ganapathi MK and Ganapathi R: Roles of NF-kappaB and 26 S proteasome in apoptotic cell death induced by topoisomerase I and II poisons in human nonsmall cell lung carcinoma. J Biol Chem 276: 8029-8036, 2001.
10. Sun XM, MacFarlane M, Zhuang J, Wolf BB, Green DR and Cohen GM: Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J Biol Chem 274: 5053-5060, 1999.
11. Grabowski DR, Dubyak GR, Rybicki L, Hidaka H and Ganapathi R: Tumor cell resistance to topoisomerase II poisons: role for intracellular free calcium in the sensitization by inhibitors or calcium-calmodulin-dependent enzymes. Biochem Pharmacol 56: 345-349, 1998.
12. Yang Y, Fang S, Jensen JP, Weissman AM and Ashwell JD: Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 288: 874-877, 2000.
13. Tamm I, Korriblau SM, Segall H, Krajewski S, Welsh K, Kitada S, Scudiero DA, Tudor G, Qui YH, Monks A, Andreeff M and Reed JC: Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res 6: 1796-1803, 2000.